By Kevin E. Noonan — Rising drug prices is an issue that everyone from the President to both Houses of Congress (Democrats and Republicans), Wall Street, and Main Street can agree must be alleviated, and perhaps the most expensive drugs are those that treat cancer. This reality is a combination of the severity of the disease and the nature of the drugs, which are generally biologic drugs characterized by structural complexity, production difficulties, and high cost of regulatory approval. As reported in Genetic Engineering News, the trend of increasing drug prices continued among most of the top ten highest selling…
View the original article here: Cancer Drug Prices Continue to Rise
The article was originally posted on Patent Docs.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.